TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that pursuant to an amendment to its existing agreement with Amerigen Pharmaceuticals, it has agreed to continue sales and marketing of products on the Amerigen label. The agreement now covers three products currently on the market, and five other product applications on file with the FDA.